Supplier
Clifton Springs Sanitarium Co
Clifton Springs Sanitarium Co was paid $12.37M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 90791, psychiatric diagnostic evaluation — 14% of everything it billed.
33Billing provider infoCLIFTON SPRINGS SANITARIUM CO
CLIFTON SPRINGS, NY 14432
CLIFTON SPRINGS, NY 14432
33aNPI1366505463assigned 12/19/2006
33bProvider typeLong Term Care Pharmacy
28Total paid$12.37M
24GClaims188,447
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Long Term Care Pharmacy providers in New York
Rank by total paid#1 of 17
Median peer was paid$6K
This provider vs. median1,948×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,146 | $158K | |
| 2019 | 8,079 | $591K | |
| 2020 | 24,046 | $1.52M | |
| 2021 | 35,896 | $2.38M | |
| 2022 | 44,368 | $2.97M | |
| 2023 | 45,365 | $2.93M | |
| 2024incomplete | 28,547 | $1.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 14% | 5,177 | 4,529 | $1.76M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 9.4% | 14,884 | 10,874 | $1.16M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 9.0% | 10,359 | 6,813 | $1.12M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.4% | 10,886 | 10,209 | $912K |
| S9485 | Crisis intervention mental health services, per diem | 7.2% | 789 | 769 | $893K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.9% | 11,152 | 10,438 | $857K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.5% | 4,772 | 4,625 | $552K |
| 36415 | Collection of venous blood by venipuncture | 4.3% | 6,824 | 5,911 | $537K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 3,206 | 3,098 | $463K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.3% | 1,889 | 1,680 | $403K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.0% | 2,679 | 2,589 | $369K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.6% | 5,208 | 4,175 | $317K |
134 more codes
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 3,140 | $230K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.6% | 4,129 | $193K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 1,045 | $160K |
| 80053 | Comprehensive metabolic panel | 1.2% | 11,327 | $150K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.1% | 2,868 | $141K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 698 | $133K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,505 | $97K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,771 | $88K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,840 | $87K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 550 | $81K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,020 | $78K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,499 | $75K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,043 | $72K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,500 | $69K |
| 80061 | Lipid panel | <1% | 5,052 | $67K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,619 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 461 | $63K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 576 | $55K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 78 | $51K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 789 | $50K |
| 87631 | <1% | 516 | $41K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 513 | $41K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,113 | $41K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 712 | $40K |
| 87480 | <1% | 1,950 | $39K | |
| 87660 | <1% | 1,939 | $39K | |
| 87510 | <1% | 1,909 | $39K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,056 | $35K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 668 | $35K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 578 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,421 | $31K |
| 84439 | <1% | 2,282 | $29K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 285 | $28K |
| 99401 | <1% | 607 | $25K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 334 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,851 | $24K |
| 82607 | <1% | 1,916 | $24K | |
| 99402 | <1% | 403 | $20K | |
| 82043 | <1% | 1,299 | $20K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 567 | $20K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,185 | $19K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 24 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,291 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 299 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 52 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 64 | $14K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 244 | $13K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 60 | $13K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 26 | $12K |
| 86780 | <1% | 1,066 | $11K | |
| 86803 | <1% | 747 | $11K | |
| 82728 | <1% | 733 | $10K | |
| 85027 | <1% | 2,770 | $9K | |
| 82570 | <1% | 1,564 | $9K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $9K |
| 84702 | <1% | 686 | $8K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 131 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $8K |
| 83735 | <1% | 1,025 | $8K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 94 | $8K |
| 81025 | <1% | 1,016 | $8K | |
| 87340 | <1% | 678 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 714 | $8K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 90 | $6K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 111 | $6K |
| 87634 | <1% | 125 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 962 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 73 | $5K |
| 99152 | <1% | 531 | $5K | |
| 87081 | <1% | 857 | $5K | |
| 80050 | General health panel | <1% | 319 | $5K |
| 83550 | <1% | 413 | $5K | |
| 85610 | <1% | 957 | $4K | |
| D1110 | Prophylaxis - adult | <1% | 88 | $4K |
| 81001 | <1% | 1,520 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 66 | $4K |
| 83880 | <1% | 125 | $4K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 240 | $4K |
| 82746 | <1% | 250 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $3K |
| 86850 | <1% | 285 | $3K | |
| 80076 | <1% | 405 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 69 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 27 | $3K |
| 83540 | <1% | 519 | $3K | |
| 43235 | <1% | 34 | $3K | |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 39 | $3K |
| 87077 | <1% | 220 | $3K | |
| 86140 | <1% | 564 | $3K | |
| 97161 | <1% | 24 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $2K |
| 87186 | <1% | 289 | $2K | |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 19 | $2K |
| 99442 | <1% | 38 | $2K | |
| 86706 | <1% | 171 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 18 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 292 | $2K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 35 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $2K |
| 85652 | <1% | 703 | $2K | |
| D0120 | Dental checkup, returning patient | <1% | 51 | $2K |
| 86900 | <1% | 317 | $1K | |
| 86901 | <1% | 316 | $1K | |
| 87070 | <1% | 148 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 85 | $1K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 13 | $1K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 89 | $999.71 |
| D0274 | Bitewings - four radiographic images | <1% | 23 | $915.40 |
| 81003 | <1% | 446 | $858.55 | |
| 99051 | <1% | 60 | $748.27 | |
| 59025 | Fetal non-stress test | <1% | 31 | $733.25 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $640.00 |
| 86038 | <1% | 51 | $636.62 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 36 | $630.60 |
| 84480 | <1% | 39 | $574.87 | |
| 83520 | <1% | 40 | $547.96 | |
| 99441 | <1% | 25 | $509.87 | |
| 86762 | <1% | 66 | $468.14 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $464.04 |
| 86704 | <1% | 30 | $421.36 | |
| 84403 | <1% | 12 | $366.17 | |
| 84703 | <1% | 42 | $356.24 | |
| D0140 | Limited oral evaluation - problem focused | <1% | 13 | $315.57 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 17 | $301.14 |
| 90686 | <1% | 12 | $219.71 | |
| 83001 | <1% | 14 | $203.42 | |
| 84146 | <1% | 12 | $199.21 | |
| 83655 | <1% | 13 | $183.04 | |
| 87088 | <1% | 13 | $141.73 | |
| 83690 | <1% | 26 | $124.92 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 26 | $121.09 |
| 82550 | <1% | 13 | $77.52 | |
| 96127 | <1% | 20 | $72.40 | |
| 82248 | <1% | 13 | $47.62 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATTON, PATRICIA (MANAGER PROVIDER ENROLLMENT)
| Provider | Location | Paid |
|---|---|---|
| The Unity Hospital of Rochester | Rochester, NY | $535K |
| Western New York Medical Practice P.C | Rochester, NY | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.